Financial statements Centrala Farmaceutyczna Hasco-Lek
Cash flow statement of Centrala Farmaceutyczna Hasco-Lek
Company age:
Age:
13 y. 22 d.
Share capital:
Share capital:
100 000 PLN
Cash inflows of CENTRALA FARMACEUTYCZNA HASCO-LEK
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Net cash from operating expenses | 2 526 911,99 | 2 102 767,48 | 491 804,52 | 764 333,84 | 516 842,36 | 307 248,85 |
| Net cash flow from investing activities | 1 529 779,04 | 910 472,38 | 502 521,33 | 670 930,59 | 155 356,28 | -1 332 630,74 |
| Net cash flow from financial activities | -4 236 090,09 | -2 561 656,64 | -2 000 000,00 | -2 000 000,00 | 0,00 | 0,00 |
| Total net cash flow | -179 399,06 | 451 583,22 | -1 005 674,15 | -564 735,57 | 672 198,64 | -1 025 381,89 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.